Cite Filings / PLX / 0001104659-22-047864

Feed Companies Filings Check

Sign in

S-3

Registration Statement

Protalix BioTherapeutics, Inc. Filed 2022-04-20 Acc 0001104659-22-047864

Documents 1

S-3 Registration Statement , tm2212977d1_s3.htm

Around this filing

2025-04-28 S-3 Registration Statement
2022-04-27 CORRESP Correspondence Between Filers and SEC Staff
2022-04-25 UPLOAD SEC-generated Letter
2022-04-20 S-3 Registration Statement
2022-04-14 PRE 14A Proxy Statement (Preliminary)
2022-04-13 4 President and CEO bought 68,000 shares at $1.50 ($102,000)
2020-04-17 S-3 Registration Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading tm2212977d1_s3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…